B Cell Alloimmunity

B Cell Alloimmunity is a pathological immune mechanism, within the broader class of alloimmune responses, distinguished by the activation and differentiation of B lymphocytes into alloantibody-producing plasma cells that specifically target donor major or minor histocompatibility antigens following transplantation.

115

Publications

6.4K

Citations

547

Authors

171

Institutions

Publications per year

2017–2026

5

Authors

547

  1. DL
    Dean L. Mann

    National Cancer Institute, United States

    5 publications · 394 citations

    5

    h-index

  2. IF
    Ian F. C. McKenzie

    Austin Hospital, Australia

    5 publications · 115 citations

    5

    h-index

  3. UH
    Ulrich Hämmerling

    Memorial Sloan Kettering Cancer Center, United States

    4 publications · 314 citations

    4

    h-index

  4. PI
    Paul I. Terasaki

    University of California, Los Angeles, United States

    4 publications · 98 citations

    4

    h-index

  5. PC
    Pierre‐André Cazenave

    Institut Pasteur, France

    3 publications · 68 citations

    3

    h-index

1–5 of 547

Venues

  1. The Journal of Immunology

    JI · 20 publications · 575 citations

    15

    h-index

  2. The Journal of Experimental Medicine

    10 publications · 675 citations

    10

    h-index

  3. PubMed

    Repository · 8 publications · 251 citations

    8

    h-index

  4. Transplantation

    7 publications · 143 citations

    7

    h-index

  5. Immunogenetics

    6 publications · 392 citations

    6

    h-index

1–5